牛牛AI助理已提取核心訊息
Conduit Pharmaceuticals Inc., previously known as Murphy Canyon Acquisition Corp., filed an amended Schedule 13G/A with the SEC, indicating that Saba Capital Management, L.P., and its associated entities, including Boaz R. Weinstein and Saba Capital Management GP, LLC, no longer hold a beneficial ownership of more than 5% of the company's common stock as of December 31, 2023. The filing, dated February 8, 2024, specifies that the shares were not acquired for the purpose of changing or influencing the control of Conduit Pharmaceuticals. The principal executive offices of Conduit Pharmaceuticals are located in San Diego, California, while Saba Capital Management operates out of New York, New York.
Conduit Pharmaceuticals Inc., previously known as Murphy Canyon Acquisition Corp., filed an amended Schedule 13G/A with the SEC, indicating that Saba Capital Management, L.P., and its associated entities, including Boaz R. Weinstein and Saba Capital Management GP, LLC, no longer hold a beneficial ownership of more than 5% of the company's common stock as of December 31, 2023. The filing, dated February 8, 2024, specifies that the shares were not acquired for the purpose of changing or influencing the control of Conduit Pharmaceuticals. The principal executive offices of Conduit Pharmaceuticals are located in San Diego, California, while Saba Capital Management operates out of New York, New York.
Conduit Pharmicals Inc.（前身爲墨菲峽谷收購公司）向美國證券交易委員會提交了經修訂的附表13G/A，表明截至2023年12月31日，薩巴資本管理有限責任公司及其關聯實體，包括波阿斯溫斯坦和薩巴資本管理GP, LLC不再持有該公司普通股5％以上的實益所有權。這份日期爲2024年2月8日的文件指出，收購這些股票不是爲了改變或影響Conduit Pharmicals的控制權。Conduit Pharmicals的主要行政辦公室位於加利福尼亞州的聖地亞哥，而薩巴資本管理公司則在紐約州紐約以外的地方開展業務。
Conduit Pharmicals Inc.（前身爲墨菲峽谷收購公司）向美國證券交易委員會提交了經修訂的附表13G/A，表明截至2023年12月31日，薩巴資本管理有限責任公司及其關聯實體，包括波阿斯溫斯坦和薩巴資本管理GP, LLC不再持有該公司普通股5％以上的實益所有權。這份日期爲2024年2月8日的文件指出，收購這些股票不是爲了改變或影響Conduit Pharmicals的控制權。Conduit Pharmicals的主要行政辦公室位於加利福尼亞州的聖地亞哥，而薩巴資本管理公司則在紐約州紐約以外的地方開展業務。
有用
沒用